Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia

Clinical trial NCT02520102 · WITHDRAWN

Trial details

NCT number: NCT02520102
Sponsor: Sanofi
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia NOS

Start date: 2017-02-01
Primary completion: 2017-02-28
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.